ArticleCurrent pharmaceutical design2026
Development of Satranidazole HCl-Loaded Oral Nanoparticulate Formulation for Colon Targeting and Colon Cancer Therapy Associated with Inflammatory Bowel Disease.
Debgopal Ganguly et al.PubMed ↗Publisher ↗
No numbers read from the abstract.